In a recent genome-wide CRISPR-Cas9 screen of Nalm6, a BCP-ALL cell line, DR5, was identified as one of key mediators of anti-CD19 CAR T-cell cytotoxicity [17]. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.